Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (74)
Giuseppe Lisco, Anna De Tullio, Michele Iovino, Olga Disoteo, Edoardo Guastamacchia, Vito Angelo Giagulli & Vincenzo Triggiani. (2023) Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes. Biomedicines 11:11, pages 2993.
Crossref
Crossref
Lijun Zhang, Guo Li & Meiyan Liu. (2023) A meta-analysis on the association between SSRIs and blood pressure in patients with CVD and depression. Journal of Affective Disorders 340, pages 181-188.
Crossref
Crossref
Katarína Krivošíková, Zora Krivošíková, Ladislava Wsolová, Tomáš Seeman & Ľudmila Podracká. (2022) Hypertension in obese children is associated with vitamin D deficiency and serotonin dysregulation. BMC Pediatrics 22:1.
Crossref
Crossref
Malak Itani, Adeel Haq, Manik Amin, Joyce Mhlanga, Daniel Lenihan, Amir Iravani & Nikolaos A Trikalinos. (2021)
Myocardial uptake of
68
Ga-DOTATATE: correlation with cardiac disease and risk factors
. Acta Radiologica 63:9, pages 1166-1172.
Crossref
Crossref
Abhijit Paul, Salman Azhar, Phonindra Nath Das, Nandadulal Bairagi & Samrat Chatterjee. (2022) Elucidating the metabolic characteristics of pancreatic β-cells from patients with type 2 diabetes (T2D) using a genome-scale metabolic modeling. Computers in Biology and Medicine 144, pages 105365.
Crossref
Crossref
Gerald Soslau. (2021) Cardiovascular serotonergic system: Evolution, receptors, transporter, and function. Journal of Experimental Zoology Part A: Ecological and Integrative Physiology 337:2, pages 115-127.
Crossref
Crossref
Marina Rieder, Nadine Gauchel, Christoph Bode & Daniel Duerschmied. (2020) Serotonin: a platelet hormone modulating cardiovascular disease. Journal of Thrombosis and Thrombolysis 52:1, pages 42-47.
Crossref
Crossref
Donghoon Han, Jae Hyuk Choi, Sehun Kim, Sang Min Park, Dong Geum Shin, Min-Kyung Kang, Seonghoon Choi, Namho Lee & Jung Rae Cho. (2020) Changes in serum serotonin levels in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention. Journal of International Medical Research 48:12, pages 030006052097010.
Crossref
Crossref
Xiali Zhong, Georgina Harris, Lena Smirnova, Valentin Zufferey, Rita de Cássia da Silveira e Sá, Fabiele Baldino Russo, Patricia Cristina Baleeiro Beltrao Braga, Megan Chesnut, Marie-Gabrielle Zurich, Helena T. Hogberg, Thomas Hartung & David Pamies. (2020) Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Alireza Zabihihesari, Arthur J. Hilliker & Pouya Rezai. (2020)
Localized microinjection of intact
Drosophila melanogaster
larva to investigate the effect of serotonin on heart rate
. Lab on a Chip 20:2, pages 343-355.
Crossref
Crossref
Pradhum Ram, Jorge L. Penalver, Kevin Bryan U. Lo, Janani Rangaswami & Gregg S. Pressman. (2019) Carcinoid Heart Disease: Review of Current Knowledge. Texas Heart Institute Journal 46:1, pages 21-27.
Crossref
Crossref
Stephen H. Boyle, Beverly H. Brummett, Cynthia M. Kuhn, John C. Barefoot, Ilene C. Siegler, Redford B. Williams & Anastasia Georgiades. (2019) The Effects of Tryptophan Enhancement and Depletion on Plasma Catecholamine Levels in Healthy Individuals. Psychosomatic Medicine 81:1, pages 34-40.
Crossref
Crossref
Saurabh Chaturvedi, Durga Prasanna Misra, Narayan Prasad, Kailash Rastogi, Harshit Singh, Mohit Kumar Rai & Vikas Agarwal. (2018)
5-HT
2
and 5-HT
2B
antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-β1 induced non-canonical signaling pathways including STAT3 : implications for fibrotic diseases like scleroderma
. International Journal of Rheumatic Diseases 21:12, pages 2128-2138.
Crossref
Crossref
Matthew R. Stoyek, Michael G. Jonz, Frank M. Smith & Roger P. Croll. (2017) Distribution and chronotropic effects of serotonin in the zebrafish heart. Autonomic Neuroscience 206, pages 43-50.
Crossref
Crossref
S.J. Fenning, D.E. Newby, C. Toumpanakis & M.W.J. Strachan. (2016) Coronary artery spasm secondary to carcinoid syndrome. QJM 109:7, pages 483-484.
Crossref
Crossref
I. K. Grazhdan, F. Yu. Kopylov, V. I. Barsky, A. V. Kirillov, O. B. Kozlova & M. G. Aksyonova. (2016) Association of 5-HT2A (A-1438G) receptor genotypes with the debut of coronary artery disease and personal anxiety. Kardiologiya i serdechno-sosudistaya khirurgiya 9:1, pages 58.
Crossref
Crossref
Pierre Meschin, Marie Demion, Olivier Cazorla, Amanda Finan, Jérôme Thireau, Sylvain Richard & Alain Lacampagne. (2015) p11 modulates calcium handling through 5-HT4R pathway in rat ventricular cardiomyocytes. Cell Calcium 58:6, pages 549-557.
Crossref
Crossref
P. C. Ferro Lopes, N. Nunes, D. P. Paula, C. T. D. Nishimori, J. V. Moro, E. D. V. Conceição & P. S. P. Santos. (2015) Cardiopulmonary parameters in propofol- or thiopental-anesthetized dogs induced to pulmonary hypertension by serotonin. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 67:5, pages 1231-1240.
Crossref
Crossref
H. Lefebvre, C. Duparc, G. Prévost, M.C. Zennaro, J. Bertherat & E. Louiset. (2015) Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms. Molecular and Cellular Endocrinology 408, pages 198-204.
Crossref
Crossref
Zubova Yulia, Nasyrova Diana, Sapronova Anna & Ugrumov Michael. (2014) Brain as an endocrine source of circulating 5-hydroxytryptamine in ontogenesis in rats. Molecular and Cellular Endocrinology 393:1-2, pages 92-98.
Crossref
Crossref
Brian D. Moore, Dallas M. Hyde, Lisa A. Miller, Emily M. Wong & Edward S. Schelegle. (2014) Persistence of Serotonergic Enhancement of Airway Response in a Model of Childhood Asthma. American Journal of Respiratory Cell and Molecular Biology 51:1, pages 77-85.
Crossref
Crossref
Lilia S. Urzedo-Rodrigues, Hilda S. Ferreira, Rejane Conceição Santana, Carla Patrícia Luz, Camila F. Perrone & Josmara B. Fregoneze. (2014) Blockade of 5-Ht3 receptors in the septal area increases Fos expression in selected brain areas. Autonomic Neuroscience 181, pages 55-68.
Crossref
Crossref
H Lefebvre, G Prévost & E Louiset. (2013) MECHANISMS IN ENDOCRINOLOGY: Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism. European Journal of Endocrinology 169:5, pages R115-R138.
Crossref
Crossref
Yoji Kato, Alexander V. Peskin, Nina Dickerhof, D. Tim Harwood & Anthony J. Kettle. (2012) Myeloperoxidase Catalyzes the Conjugation of Serotonin to Thiols via Free Radicals and Tryptamine-4,5-dione. Chemical Research in Toxicology 25:11, pages 2322-2332.
Crossref
Crossref
Keren Ofek, Karl Schoknecht, Naomi Melamed‐Book, Uwe Heinemann, Alon Friedman & Hermona Soreq. (2012)
Fluoxetine induces vasodilatation of cerebral arterioles by co‐modulating
NO
/muscarinic signalling
. Journal of Cellular and Molecular Medicine 16:11, pages 2736-2744.
Crossref
Crossref
Kartik Balachandran, Samiya Hussain, Choon-Hwai Yap, Muralidhar Padala, Adrian H. Chester & Ajit P. Yoganathan. (2012) Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT2A receptor-dependent pathway. Cardiovascular Pathology 21:3, pages 206-213.
Crossref
Crossref
Luca CarnevaliEvgeny BondarenkoAndrea SgoifoFrederick R. WalkerGeoffrey A. Head, Elena V. Lukoshkova, Trevor A. DayEugene Nalivaiko. (2011) Metyrapone and fluoxetine suppress enduring behavioral but not cardiac effects of subchronic stress in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 301:4, pages R1123-R1131.
Crossref
Crossref
Takuji Machida, Misa Ohta, Akina Onoguchi, Kenji Iizuka, Mio Sakai, Masaru Minami & Masahiko Hirafuji. (2011) 5-Hydroxytryptaime induces cyclooxygenase-2 in rat vascular smooth muscle cells: Mechanisms involving Src, PKC and MAPK activation. European Journal of Pharmacology 656:1-3, pages 19-26.
Crossref
Crossref
Francine Rendu, Katell Peoc’h, Ivan Berlin, Daniel Thomas & Jean-Marie Launay. (2011) Smoking Related Diseases: The Central Role of Monoamine Oxidase. International Journal of Environmental Research and Public Health 8:1, pages 136-147.
Crossref
Crossref
Lilia S. Urzedo-Rodrigues, Hilda S. Ferreira, Daniela O. Almeida, João Paulo Medeiros, Átila Batista, Emilio de Castro e Silva & Josmara B. Fregoneze. (2011) Blockade of 5-HT3 receptors at septal area increase blood pressure in unanaesthetized rats. Autonomic Neuroscience 159:1-2, pages 51-61.
Crossref
Crossref
V. Ben Sivarajan, Steven M. Schwartz & Julien I.E. Hoffman. 2011. Pediatric Critical Care. Pediatric Critical Care
199
216
.
Stacy L. Porvasnik, Sean Germain, Jennifer Embury, Kimberley S. Gannon, Vincent Jacques, Justin Murray, Barry J. Byrne, Sharon Shacham & Faris Al-Mousily. (2010) PRX-08066, a Novel 5-Hydroxytryptamine Receptor 2B Antagonist, Reduces Monocrotaline-Induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats. Journal of Pharmacology and Experimental Therapeutics 334:2, pages 364-372.
Crossref
Crossref
M. V. Ugrumov. (2010) Developing Brain as an Endocrine Organ: A Paradoxical Reality. Neurochemical Research 35:6, pages 837-850.
Crossref
Crossref
John W. Adams, Juan Ramirez, Yunqing Shi, William Thomsen, John Frazer, Michael Morgan, Jeffrey E. Edwards, Weichao Chen, Bradley R. Teegarden, Yifeng Xiong, Hussien Al-Shamma, Dominic P. Behan & Daniel T. Connolly. (2009)
APD791, 3-Methoxy-
N
-(3-(1-methyl-1
H
-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a Novel 5-Hydroxytryptamine 2A Receptor Antagonist: Pharmacological Profile, Pharmacokinetics, Platelet Activity and Vascular Biology
. Journal of Pharmacology and Experimental Therapeutics 331:1, pages 96-103.
Crossref
Crossref
Apostolia Maria Tsimberidou, Luis H. Camacho, Srdan Verstovsek, Chaan Ng, David S. Hong, Cynthia K. Uehara, Catalina Gutierrez, Shawn Daring, Jan Stevens, Philip B. Komarnitsky, Brian Schwartz & Razelle Kurzrock. (2009) A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors. Clinical Cancer Research 15:14, pages 4769-4776.
Crossref
Crossref
D. I. Nasyrova, A. Ya. Sapronova, A. V. Balbashev, V. S. Kudrin, P. M. Klodt, K. S. Raevskii & M. V. Ugryumov. (2009) Development of central and peripheral serotonin-producing systems in rats in ontogenesis. Journal of Evolutionary Biochemistry and Physiology 45:1, pages 78-85.
Crossref
Crossref
M. V. Ugryumov. (2009) Endocrine functions of brain in adult and developing mammals. Russian Journal of Developmental Biology 40:1, pages 14-22.
Crossref
Crossref
Luigi Michele Pavone, Anna Spina, Roberta Lo Muto, Dionea Santoro, Vincenzo Mastellone & Luigi Avallone. (2008) Heart valve cardiomyocytes of mouse embryos express the serotonin transporter SERT. Biochemical and Biophysical Research Communications 377:2, pages 419-422.
Crossref
Crossref
A A Herbert, E J Kidd & K J Broadley. (2008) Dietary trace amine-dependent vasoconstriction in porcine coronary artery. British Journal of Pharmacology 155:4, pages 525-534.
Crossref
Crossref
Q Tang, Z-Q Li, W Li, J Guo, H-Y Sun, X-H Zhang, C-P Lau, H-F Tse, S Zhang & G-R Li. (2008)
The 5-HT
2
antagonist ketanserin is an open channel blocker of human cardiac
ether-à-go-go
-related gene (hERG) potassium channels
. British Journal of Pharmacology 155:3, pages 365-373.
Crossref
Crossref
Maria A. Stasi, Stefano Di Serio, Mario Vertechy, Antonio Schiavone, Orlando Ghirardi, Patrizia Minetti, Giuseppe Campiani, Franco Borsini & Paolo Carminati. (2007) ST2472: a new potential antipsychotic with very low liability to induce side-effects. The International Journal of Neuropsychopharmacology 11:03.
Crossref
Crossref
John W. Adams, Juan Ramirez, Danny Ortuno, Yunqing Shi, William Thomsen, Jeremy G. Richman, Michael Morgan, Peter Dosa, Bradley R. Teegarden, Hussien Al-Shamma, Dominic P. Behan & Daniel T. Connolly. (2008) Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist. European Journal of Pharmacology 586:1-3, pages 234-243.
Crossref
Crossref
Indrani Halder, Matthew F. Muldoon, Robert E. Ferrell & Stephen B. Manuck. (2007)
Serotonin Receptor 2A (
HTR2A
) Gene Polymorphisms Are Associated with Blood Pressure, Central Adiposity, and the Metabolic Syndrome
. Metabolic Syndrome and Related Disorders 5:4, pages 323-330.
Crossref
Crossref
Sheritha P. Lee, Kenneth I. Ataga, Mohamed Zayed, Jeanne M. Manganello, Eugene P. Orringer, David R. Phillips & Leslie V. Parise. (2007) Phase I study of eptifibatide in patients with sickle cell anaemia. British Journal of Haematology 139:4, pages 612-620.
Crossref
Crossref
Luigi Michele Pavone, Pratibha Mithbaokar, Vincenzo Mastellone, Luigi Avallone, Patricia Gaspar, Veeramani Maharajan & Antonio Baldini. (2007) Fate map of serotonin transporter‐expressing cells in developing mouse heart. genesis 45:11, pages 689-695.
Crossref
Crossref
A. A. Mustafin, R. R. Nigmatullina & L. M. Mirolyubov. (2006) Functional activity of 5-HT4 receptors in children with congenital heart disease. Bulletin of Experimental Biology and Medicine 142:6, pages 717-719.
Crossref
Crossref
Christine Bourgault, Sebastien Bergeron, Peter Bogaty & Paul Poirier. (2006) A most unusual acute coronary syndrome. Canadian Journal of Cardiology 22:5, pages 429-432.
Crossref
Crossref
Miyuki YAMAMOTO, Jing Ji JIN, Zhihong WU, Michiko ABE, Yasuharu TABARA, Tokihisa NAGAI, Eiji YAMASAKI, Michiya IGASE, Katsuhiko KOHARA, Tetsuro MIKI & Jun NAKURA. (2006) Interaction between Serotonin 2A Receptor and Endothelin-1 Variants in Association with Hypertension in Japanese. Hypertension Research 29:4, pages 227-232.
Crossref
Crossref
Julien I.E. Hoffman. 2006. Pediatric Critical Care. Pediatric Critical Care
203
224
.
Hilda Silva Ferreira, Elenilda Oliveira, Thiallan Nery Faustino, Emilio de Castro e Silva & Josmara Bartolomei Fregoneze. (2005) Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats. Brain Research 1040:1-2, pages 64-72.
Crossref
Crossref
Tatsuya Muto, Yoshihiro Hotta, Kunihiro Miyazeki, Hiroaki Ando, Naohisa Ishikawa, Takaaki Hasegawa, Yumi Sugimoto, Jun Yamada & Yasuyoshi Miki. (2005) Protective effects of sarpogrelate, a 5-HT2A antagonist, against postischemic myocardial dysfunction in guinea-pig hearts. Molecular and Cellular Biochemistry 272:1-2, pages 119-132.
Crossref
Crossref
Lauren A Weiss, Jeremy Veenstra-VanderWeele, Dina L Newman, Soo-Jeong Kim, Harvey Dytch, Mary Sara McPeek, Suzanne Cheng, Carole Ober, Edwin H CookJrJr & Mark Abney. (2004) Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. European Journal of Human Genetics 12:11, pages 949-954.
Crossref
Crossref
Hilda Silva Ferreira, Emilio de Castro e Silva, Carla Cointeiro, Elenilda Oliveira, Thiallan Nery Faustino & Josmara Bartolomei Fregoneze. (2004) Role of central 5-HT3 receptors in the control of blood pressure in stressed and non-stressed rats. Brain Research 1028:1, pages 48-58.
Crossref
Crossref
Takafumi Nagatomo, Mamunur Rashid, Habib Abul Muntasir & Tadazumi Komiyama. (2004) Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. Pharmacology & Therapeutics 104:1, pages 59-81.
Crossref
Crossref
Ulrike Eder, Martina Butter, Edith Zirbisegger, Lydia Reinsberger, Franz Bucar, Reinhold Wintersteiger & Heinz Juan. (2004) Influence of several Styrian wines on bovine coronary artery contractions induced by endogenous agents. Journal of Biochemical and Biophysical Methods 61:1-2, pages 169-182.
Crossref
Crossref
A. E. Lychkova. (2004) Effect of serotoninergic and cholinergic nervous systems and corresponding neurotransmitters on heart function and motor activity of pelvic smooth muscle organs. Bulletin of Experimental Biology and Medicine 138:4, pages 325-329.
Crossref
Crossref
A. E. Lychkova. (2004) Effect of serotoninergic and cholinergic nervous systems and corresponding neurotransmitters on heart function and motor activity of pelvic smooth muscle organs. Bulletin of Experimental Biology and Medicine 138:4, pages 325-329.
Crossref
Crossref
A. E. Lychkova. (2004) Effect of serotoninergic and cholinergic nervous systems and corresponding neurotransmitters on heart function and motor activity of pelvic smooth muscle organs. Bulletin of Experimental Biology and Medicine 138:10, pages 325-329.
Crossref
Crossref
Jennie E. Larkin, Bryan C. Frank, Renee M. Gaspard, Irena Duka, Haralambos Gavras & John Quackenbush. (2004) Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiological Genomics 18:2, pages 152-166.
Crossref
Crossref
H Iwakuma. (2004) Electroencephalographical Effects of Sarpogrelate Hydrochloride versus Ticlopidine Hydrochloride in Elderly Patients with Peripheral Atherosclerosis. Journal of International Medical Research 32:3, pages 274-283.
Crossref
Crossref
Francine Côté, Cécile Fligny, Yves Fromes, Jacques Mallet & Guilan Vodjdani. (2004) Recent advances in understanding serotonin regulation of cardiovascular function. Trends in Molecular Medicine 10:5, pages 232-238.
Crossref
Crossref
Michael Levin. (2004) A novel immunohistochemical method for evaluation of antibody specificity and detection of labile targets in biological tissue. Journal of Biochemical and Biophysical Methods 58:1, pages 85-96.
Crossref
Crossref
Cynthia Mlakar, Katrina Simpson & Ronald Watson*. 2003. Nutrition and Heart Disease. Nutrition and Heart Disease.
Robert Pohl, Richard Balon, Anusha Jayaraman, Ronald G Doll & Vikram Yeragani. (2003) Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans. Journal of Psychosomatic Research 55:3, pages 247-251.
Crossref
Crossref
Canan G. NebigilLuc Maroteaux. (2003)
Functional Consequence of Serotonin/5-HT
2B
Receptor Signaling in Heart
. Circulation 108:7, pages 902-908.
Crossref
Crossref
Canan G. NebigilFabrice JaffréNadia MessaddeqPierre HickelLaurent MonassierJean-Marie LaunayLuc Maroteaux. (2003)
Overexpression of the Serotonin 5-HT
2B
Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy
. Circulation 107:25, pages 3223-3229.
Crossref
Crossref
Canan G. Nebigil, Nelly Etienne, Nadia Messaddeq & Luc Maroteaux. (2003)
Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5‐HT
2B
‐receptor signaling
. The FASEB Journal 17:10, pages 1373-1375.
Crossref
Crossref
Donald J. AbrahamGregory S. Bisacchi. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
283
338
.
Timothy Niacaris & Leon Avery. (2003)
Serotonin regulates repolarization of the
C. elegans
pharyngeal muscle
. Journal of Experimental Biology 206:2, pages 223-231.
Crossref
Crossref
Jean-Marie Launay. (2003) Sérotonine et système cardio-vasculaire : rôle du récepteur sérotoninergique 5-HT2B. Bulletin de l'Académie Nationale de Médecine 187:1, pages 117-127.
Crossref
Crossref
Brian J Jones & Thomas P Blackburn. (2002) The medical benefit of 5-HT research. Pharmacology Biochemistry and Behavior 71:4, pages 555-568.
Crossref
Crossref
Moo-Yeol Lee, Ok-Nam Bae, Seung-Min Chung, Kyu-Tae Kang, Joo-Young Lee & Jin-Ho Chung. (2002) Enhancement of Platelet Aggregation and Thrombus Formation by Arsenic in Drinking Water: A Contributing Factor to Cardiovascular Disease. Toxicology and Applied Pharmacology 179:2, pages 83-88.
Crossref
Crossref
P.R. Belcher & A.J. Drake-Holland. (2001) Serotonin reuptake inhibitors and cardiovascular disease. Coronary Health Care 5:3, pages 141-147.
Crossref
Crossref
Jeremy Veenstra-VanderWeele, George M Anderson & Edwin H CookJr.Jr.. (2000) Pharmacogenetics and the serotonin system: initial studies and future directions. European Journal of Pharmacology 410:2-3, pages 165-181.
Crossref
Crossref